预测未来的肺癌生存率:基于人口的癌症生存模型研究
Fan-Tsui Meng1,2, Jing-Rong Jhuang3, Yan-Teng Peng2
1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
JMIR public health and surveillance
|May 31, 2024
概括
台湾的肺癌生存率正在改善,预测到2020年,5年生存率为38.7%. 这一进展表明肺野心联盟.
科学领域:
- 瘤学和公共卫生
- 流行病学建模 流行病学建模
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 晚期诊断显著影响患者的预后和生存率.
- 肺野心联盟的目标是到2025年将肺癌5年生存率提高一倍.
研究的目的:
- 评估肺野心联盟在台湾实现目标的可行性.
- 为了预测未来的肺癌存活率,使用存活率-周期-队列模型.
- 分析台湾人口肺癌存活率的趋势.
主要方法:
- 对205,104名肺癌患者 (1997-2018) 的回顾性分析.
- 应用生存期-队列模型来计算生存率.
- 从1年间隔的生存数据进行推断,以预测到2020年诊断的5年结果.
主要成果:
- 2020年预测的5年生存率达到38.7%,高于2013年的23.8%.
- 从2004年开始,观察到显著的生存率改善.
- 在不同的人口统计和组织学类型中观察到不同的生存改善.
结论:
- 台湾的肺癌存活率显著提高.
- 改善归因于低剂量计算机断层扫描查,先进的诊断和治疗方法.
- 肺野心联盟的目标似乎可以通过医疗技术和卫生政策的不断进步来实现.
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Statistical Methods for Analyzing Epidemiological Data
353
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
353
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Actuarial Approach
74
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
74
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177


